Frontiers in Psychology (Mar 2018)

Development and Validation of a Specific Self-Efficacy Scale in Adherence to a Gluten-Free Diet

  • Ricardo Fueyo-Díaz,
  • Ricardo Fueyo-Díaz,
  • Rosa Magallón-Botaya,
  • Rosa Magallón-Botaya,
  • Santiago Gascón-Santos,
  • Santiago Gascón-Santos,
  • Ángela Asensio-Martínez,
  • Ángela Asensio-Martínez,
  • Guillermo Palacios-Navarro,
  • Juan J. Sebastián-Domingo,
  • Juan J. Sebastián-Domingo,
  • Juan J. Sebastián-Domingo

DOI
https://doi.org/10.3389/fpsyg.2018.00342
Journal volume & issue
Vol. 9

Abstract

Read online

The aim of this study was to develop a scale to assess the levels of specific self-efficacy in order to enhance adherence to a gluten-free diet and the life quality of celiac patients. Celiac disease is a chronic small intestinal immune-mediated enteropathy precipitated by exposure to dietary gluten in genetically predisposed people. The only treatment is a strict lifelong gluten-free diet. Within the framework of Social Cognitive Theory, expectation of self-efficacy is understood as the degree in which a person believes himself to be capable of performing a certain task (e.g., adhering to a gluten-free diet), a construct which has been widely studied in its relation with adopting healthy behaviors, but scarcely in relation to celiac disease. A validation study was carried out in various stages: preparation of the protocol; construction of the questionnaire and a pilot run with 20 patients; validation of the scale with 563 patients and statistical analysis. A 25-item scale was developed. Feasibility was excellent (99.82% of participants completed all the questions). Factorial analysis pointed to the existence of five factors that explained 70.98% of the variance with a Cronbach alpha of 0.81 for the scale overall and between 0.64 and 0.90 for each factor. The scale showed a Spearman's Rho coefficient of 0.279 with the General self-efficacy Scale. This easily administered scale provides good psychometric properties for evaluating specific self-efficacy of celiac patients in adhering to treatment. It seeks to be the first scale that provides not only a measurement of specific self-efficacy in celiac disease, but also to determine its levels for each of the areas as a first step toward designing interventions of self-management and empowerment programs to cope with the disease.

Keywords